Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
Financials
Financial year 2024
PHARMACIE ARNAUD NICOLAS from Elsene, company number BE0505804619, closed financial year 2024 with a result of € -10,452 after tax. For that financial year PHARMACIE ARNAUD NICOLAS recorded a gross margin of € 20,066 and equity of € -57,542. Compared with financial year 2023, the result moved from € -97 to € -10,452. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ -57,542
▼ € 10,452 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -10,452
▼ 10714 % more loss than in 2023
Profit after tax over the fiscal year.
€ 5,129
▼ 60% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -69,942.
Debts at end 2024
€ 135,321
▼ 17% vs 2023
€ 27,700 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 120,442
▲ 46% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 8
▼ € 3,316 vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 61,547 | € 59,182 | € 45,233 | € 20,066 | ▼ 56% |
| Profit after taxes | € 14,741 | € 9,238 | € -97 | € -10,452 | ▼ € 10,355 |
| Equity | € -62,772 | € -53,534 | € -47,091 | € -57,542 | ▼ € 10,452 |
| Total debts | € 275,444 | € 242,966 | € 283,197 | € 277,711 | ▼ 2% |
| Cash | € 7,005 | € 22,331 | € 12,668 | € 5,129 | ▼ 60% |
| Retained profit | € -75,172 | € -65,934 | € -59,491 | € -69,942 | ▼ € 10,452 |
| Bank debt | € 213,865 | € 175,168 | € 162,683 | € 135,321 | ▼ 17% |
| Balance sheet total | € 212,672 | € 189,432 | € 236,106 | € 220,169 | ▼ 7% |
Key figures of PHARMACIE ARNAUD NICOLAS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMACIE ARNAUD NICOLAS?
What happened at PHARMACIE ARNAUD NICOLAS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 10,452. filed late Source: NBB ↗
- Defopharma SRL became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 14,741 profit in 2021 to € 10,452 loss in 2024.
Paid € 3,881 in corporate taxes since 2021.
Best year ever: 2021, with € 14,741 profit.
A new publication or filing at PHARMACIE ARNAUD NICOLAS? We notify you, reason included.
Follow PHARMACIE ARNAUD NICOLASDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DEFOPHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE ARNAUD NICOLASBehind PHARMACIE ARNAUD NICOLAS is Defopharma SRL. The shares are held by DEFOPHARMA (100%).
Directors
According to the 2024 annual accounts
Director · represented by Victor Djouguela Defo
since 2019
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Raadstraat 44
1050 Elsene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0505.804.619
- VAT number
- BE 0505.804.619
- Registered office
- Raadstraat 44, 1050 Elsene
- Names & denominations
- PHARMACIE ARNAUD NICOLAS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 November 2014
- Peppol
- Active · Active since 6 Mar 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen